This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016-2020.
Company Filing History:
Years Active: 2016-2020
Title: Innovations of Markus Britschgi
Introduction
Markus Britschgi is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to his name, Britschgi's work has the potential to impact various medical applications.
Latest Patents
Among his latest patents are the "Anti-alpha-synuclein antibodies and methods of use." This invention provides anti-human alpha-synuclein antibodies and outlines methods for utilizing these antibodies effectively. The focus on alpha-synuclein is crucial, as it is associated with neurodegenerative diseases, making this innovation particularly relevant in the medical field.
Career Highlights
Markus Britschgi is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field, enhancing the development of innovative solutions in biotechnology.
Collaborations
Throughout his career, Britschgi has worked alongside notable colleagues such as Klaus Kaluza and Olaf Mundigl. These collaborations have fostered a productive environment for innovation and research, contributing to the advancement of their shared goals in biotechnology.
Conclusion
Markus Britschgi's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.